MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-31.

Income Overview

Net Income
-$30,060,333
EPS
-$0.63
Unit: Dollar

Income Statement
2025-12-31
Research and development expenses
20,532,670
Acquisition-related costs (note 5)
3,679,618
General and administrative expenses
7,583,651
Operating loss
31,795,939
Employee retention tax credit
113,574
Grant income
713,508
Interest expense
625,283
Interest income
136,233
Change in fair value of kineta merger holdback shares
1,590,949
Loss on kineta employee separation payments assumed from merger
185,019
Total other income (expense)
1,743,962
Net loss
-30,051,977
Series a preferred cash dividend
8,356
Deemed dividend on warrant modifications
0
Net loss attributable to common stockholders
-30,060,333
Basic EPS
-0.63
Diluted EPS
-0.63
Basic Average Shares
47,927,196
Diluted Average Shares
47,927,196
Unit: Dollar.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Net lossattributable to common...-$30,060,333 Change in fair value ofkineta merger holdback...$1,590,949 Grant income$713,508 Interest income$136,233 Employee retention taxcredit$113,574 Net loss-$30,051,977 Series a preferred cashdividend$8,356 Total other income(expense)$1,743,962 Interest expense$625,283 Loss on kinetaemployee separation...$185,019 Operating loss$31,795,939 Research and developmentexpenses$20,532,670 General andadministrative expenses$7,583,651 Acquisition-related costs (note 5)$3,679,618

TuHURA Biosciences, Inc. NV (HURA)

TuHURA Biosciences, Inc. NV (HURA)